AmCad BioMed Corporation

Equities

4188

TW0004188008

Advanced Medical Equipment & Technology

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-05-20 pm EDT			5-day change	1st Jan Change
26.2 ^TWD	+0.19%		+0.19%	-1.87%

May. 09	AmCad BioMed Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Feb. 29	AmCad BioMed Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI

AmCad BioMed Corporation Announces Board Changes

November 06, 2020 at 02:32 am EST

AmCad BioMed Corporation announced election of deputy chairperson, effective November 6, 2020. Name and resume of the previous position holder: Lee, Yi-Li, the deputy Chairperson. Name and resume of the new position holder: Lee, YI-LING, director.

Latest news about AmCad BioMed Corporation

AmCad BioMed Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09	CI
AmCad BioMed Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
PsiQuantum, Corp., Mitsubishi UFJ Financial Group, Inc. and Mitsubishi Chemical Announces Partnership to Design Energy-Efficient Materials on PsiQuantum?s Fault-Tolerant Quantum Computer	Jan. 24	CI
AmCad BioMed Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 08	CI
AmCad BioMed Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-04	CI
AmCad BioMed Corporation Announces Management Changes	23-05-18	CI
AmCad BioMed Corporation Approves Board Changes	23-05-18	CI
AmCad BioMed Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11	CI
AmCad Biomed Corporation Appoints Maureen Chang as Corporate Governance Officer	23-05-03	CI
AmCad BioMed Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-08	CI
AmCad BioMed Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-08	CI
AmCad BioMed Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-03	CI
AmCad BioMed Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-11	CI
AmCad BioMed Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-09	CI
AmCad BioMed Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-21	CI
AmCad BioMed Corporation Appoints Maureen Chang as Spokesperson, Financial Officer and Accounting Officer	22-02-18	CI
AmCad BioMed Corporation cancelled the transaction announced on May 21, 2021	22-02-17	CI
AmCad BioMed Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-05	CI
AmCad BioMed Corporation Announces Receiving FDA Approval of AmCad UTdeep Learning Advanced Version	21-09-09	CI
AmCad BioMed Corporation announced a financing transaction	21-05-20	CI
Amcad Biomed Corporation Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-09	CI
AmCad BioMed Corporation Announces Executive Changes	21-05-07	CI
Amcad Biomed Corporation Reports Earnings Results for the Full Year Ended December 31, 2020	21-02-22	CI
Amcad Biomed Corporation Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-09	CI
AmCad BioMed Corporation Announces Board Changes	20-11-06	CI

Chart AmCad BioMed Corporation

Duration

Period

More charts

Company Profile

AmCad BioMed Corporation is a Taiwan-based company principally engaged in the research, development and manufacture of computer-aided diagnosis (CAD) medical equipment. The Companyâs products include AmCAT-UT Dection, which is a computer-aided detection system of thyroid ultrasound, and AmCAD-UT Diagnosis, which is a computer-aided diagnosis system of thyroid ultrasound. The Company operates in Taiwan, China and Hong Kong markets.

Sector

Advanced Medical Equipment & Technology

More about the company

Income Statement Evolution

More financial data

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
AMCAD BIOMED CORPORATION	-1.87%	43.19M
SARTORIUS AG	-18.82%	18.18B
QUIDELORTHO CORPORATION	-43.89%	2.84B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+23.49%	1.94B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-3.70%	1.64B
BIOTAGE AB	+31.41%	1.33B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-16.85%	953M
CONTEC MEDICAL SYSTEMS CO.,LTD	-23.12%	891M
REVENIO GROUP OYJ	+3.17%	865M
CELLAVISION AB	+24.76%	543M

Medical Diagnostic & Testing Equipment